LabCorp Newswire

LabCorp Newswire

Comprehensive Real-Time News Feed for LabCorp.

Results 1 - 20 of 159 in LabCorp

  1. Laboratory Corp. of America Holdings (LH) Scheduled to Post Earnings on WednesdayRead the original story w/Photo

    41 min ago | AmericanBankingNews.com

    ... in providing clinical laboratory services and drug development support. The Company operates through two segments: LabCorp Diagnostics (LCD) and Covance Drug Development (CDD). Receive News & Ratings for Laboratory Corp. of America Holdings Daily - ...

    Comment?

  2. Laboratory Corp. of America Holdings (LH) Sets New 1-Year High at $138.21Read the original story w/Photo

    Friday Jul 22 | Daily Political

    ... d in providing clinical laboratory services and drug development support. The Company operates through two segments: LabCorp Diagnostics (LCD) and Covance Drug Development (CDD).

    Comment?

  3. Today's Top Gainers in the Market Laboratory Corp. of America Holdings (NYSE:LH) from HealthcareRead the original story w/Photo

    Thursday Jul 21 | The Daily Leicester

    Today's top gainers include the company Laboratory Corp. of America Holdings which is in the industry Medical Laboratories & Research , gaining -0.28% today. In the last week its performance is 1.63%, and 16.06% for the past quarter.

    Comment?

  4. Transgenomic, Inc. Licenses Commercial Rights To Its Long QT Syndrome ...Read the original story

    Tuesday Jul 19 | BioSpace

    ... President and CEO Paul Kinnon commented, "We are delighted to license our Long QT syndrome DNA testing portfolio to LabCorp, one of the premier diagnostic testing companies in the US. The portfolio includes relevant intellectual property from a ...

    Comment?

  5. Transgenomic Licenses Commercial Rights to Its Long QT Syndrome DNA Testing Portfolio to LabCorpRead the original story w/Photo

    Wednesday Jul 20 | Business Wire

    LabCorp's DNA Testing for Long QT Syndrome, a Congenital Heart Rhythm Disorder Associated with Potentially Lethal Arrhythmias, is Enhanced by TBIO's Intellectual Property )--Transgenomic, Inc. , , today announced that it has signed a commercial license agreement with Laboratory Corporation of AmericaA Holdings for TBIO's portfolio of intellectual property pertaining to DNA susceptibility testing for Long QT syndrome , a primarily congenital heart rhythm disorder that is associated with potentially lethal cardiac arrhythmias. Certain prescription medications and activities can trigger LQTS in susceptible individuals, so accurately identifying individuals at risk is important.

    Comment?

  6. LabCorp renovates, to reopen two offices downtownRead the original story w/Photo

    Friday Jul 15 | Burlington Times News

    LabCorp has completed two major renovation projects in downtown Burlington and will relocate more than 100 employees, a company spokesman said. The buildings, at 430 S. Spring St. and 448 S. Main St., were built in 1936 and 1932, respectively, according to Don Van Hagen, a LabCorp spokesman.

    Comment?

  7. Laboratory Corp. of America Holdings (LH) Hits New 1-Year High at $136.68Read the original story w/Photo

    Thursday Jul 14 | Daily Political

    ... d in providing clinical laboratory services and drug development support. The Company operates through two segments: LabCorp Diagnostics (LCD) and Covance Drug Development (CDD).

    Comment?

  8. Laboratory Corp. of America Holdings (LH) Hits New 12-Month High at $136.68Read the original story w/Photo

    Tuesday Jul 12 | Daily Political

    ... d in providing clinical laboratory services and drug development support. The Company operates through two segments: LabCorp Diagnostics (LCD) and Covance Drug Development (CDD).

    Comment?

  9. LabCorp Opens Clinical Trials Testing Facility In BelgiumRead the original story

    Dec 31, 1995 | Laboratory Network .com

    Laboratory Corp. of America Holdings' clinical trials testing business has opened a clinical trials testing facility in Mechelen, Belgium. The new laboratory will perform many of the tests offered by LabCorp in North America, including polymerase chain reaction and flowcytometry, and will use the same methodologies and instrumentation to assure combinability of data.

    Comment?

  10. Man on a 'Mission'Read the original story w/Photo

    Sunday Jul 3 | Burlington Times News

    Jeff Colgan worked for LabCorp for more than seven years, his last job being director of accounts receivable for the company's Atlantic division. "To my face, my bosses wished me well," Colgan said, chuckling as he recalled the tale one recent weekday afternoon.

    Comment?

  11. Conversion Right Triggered For LabCorp??'s Zero Coupon Convertible Subordinated Notes Due 2021Read the original story

    Thursday Jun 30 | BioSpace

    Laboratory Corporation of AmericaA Holdings announced today that its Zero Coupon Convertible Subordinated Notes due 2021 may be converted as set forth below. The Zero Coupon Notes are convertible into cash and Common Stock of LabCorp, if any, subject to the terms of the Zero Coupon Notes and the Indenture, dated as of October 24, 2006 between LabCorp and The Bank of New York Mellon, as trustee and the conversion agent.

    Comment?

  12. Conversion Right Triggered for LabCorpa s Zero Coupon Convertible Subordinated Notes Due 2021Read the original story w/Photo

    Friday Jul 1 | Business Wire

    The Zero Coupon Notes are convertible into cash and Common Stock of LabCorp, if any, subject to the terms of the Zero Coupon Notes and the Indenture, dated as of October 24, 2006 between LabCorp and The Bank of New York Mellon, as trustee and the conversion agent. In order to exercise the option to convert all or a portion of the Zero Coupon Notes, holders must validly surrender their Zero Coupon Notes at any time during the calendar quarter through the close of business at 5:00 p.m., New York City time, on Friday, September 30, 2016.

    Comment?

  13. Noninvasive Prenatal Testing Market Volume Forecast and Value Chain Analysis 2016-2020Read the original story w/Photo

    Wednesday Jun 29 | SBWire

    ... the key participants operating in the global market. Key players profiled in the report include Sequenom Inc., BGI, LabCorp, LifeCodexx AG, Natera Inc., Quest Diagnostics Incorporated, Illumina Inc., Berry Genomics, Ariosa Diagnostics and ...

    Comment?

  14. LabCorp lung cancer test OKa dRead the original story w/Photo

    Monday Jun 27 | Burlington Times News

    LabCorp has received approval for the first blood-based test for patients who have been diagnosed with non-small cell cancer, the company announced Monday. The Roche cobas EGFR Mutation Test v2 is the first blood-based test approved for clinical use in the United States to detect certain epidermal growth factor receptor gene mutations in non-small cell cancer patients, according to a statement from the company.

    Comment?

  15. LabCorp Announces Launch of New Companion Diagnostic for Non-Small Cell Lung CancerRead the original story w/Photo

    Monday Jun 27 | Business Wire

    ... clinical use in the U.S. to detect certain epidermal growth factor receptor (EGFR) gene mutations in NSCLC patients. LabCorp played a key role in making the test available upon approval by the U.S. Food and Drug Administration (FDA) and is the only ...

    Comment?

  16. Burlington MSA leads country in med labsRead the original story w/Photo

    Saturday Jun 25 | Burlington Times News

    The Burlington Metropolitan Statistical Area is the top small MSA for research, testing and medical laboratories in the country, according to a recent study. "LabCorp certainly is a huge factor," Jim Shamp, a spokesman for the N.C. Biotechnology Center, said about the ranking.

    Comment?

  17. Top Picks of Healthcare-focused Asset Manager Run by Former SAC Capital TradersRead the original story w/Photo

    Jun 21, 2016 | Insider Monkey

    ... Laboratory Corp. of America Holdings (NYSE:LH) during the first quarter of 2016, as the firm increased its stake in LabCorp by 150,000 shares during the quarter to 950,000 shares. The upped stake was valued at $111.27 million on March 31 and ...

    Comment?

  18. Ups and Downs: Vexing violence; zapping Zika; and applause for the Class of 2016Read the original story w/Photo

    Jun 10, 2016 | Burlington Times News

    ... to the virus itself, which is expected to become more prevalent in the U.S. this year. That's why we're glad to see LabCorp, our hometown company, has developed a test for the mosquito-borne virus. It has received an emergency use authorization from ...

    Comment?

  19. LabCorp Announces The Availability Of The RealStar Zika Virus TestRead the original story

    Jun 9, 2016 | Laboratory Network .com

    Laboratory Corporation of America Holdings (LabCorp) (NYSE:LH) today announced the nationwide availability of testing for Zika virus using the RealStar Zika Virus RT-PCR Kit U.S. from altona Diagnostics GmbH. The test has received Emergency Use ...

    Comment?

  20. LabCorp Is Scheduled To Present At The 36th Annual Growth Stock ConferenceRead the original story

    Jun 8, 2016 | BioSpace

    Laboratory Corporation of AmericaA Holdings today announced it will participate at the 36th Annual William Blair Growth Stock Conference. LabCorp's presentation is planned for Tuesday, June 14, 2016 at 3:50 PM .

    Comment?